4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics Statistics

Total Valuation

FDMT has a market cap or net worth of $153.80 million. The enterprise value is -$280.79 million.

Market Cap	153.80M
Enterprise Value	-280.79M

Important Dates

The last earnings date was Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

FDMT has 46.32 million shares outstanding. The number of shares has increased by 28.42% in one year.

Current Share Class	46.32M
Shares Outstanding	46.32M
Shares Change (YoY)	+28.42%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	3.90%
Owned by Institutions (%)	81.12%
Float	34.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6,686.86
Forward PS	133.52
PB Ratio	0.33
P/TBV Ratio	0.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.36, with a Debt / Equity ratio of 0.05.

Current Ratio	12.36
Quick Ratio	11.95
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -32.97% and return on invested capital (ROIC) is -22.93%.

Return on Equity (ROE)	-32.97%
Return on Assets (ROA)	-22.19%
Return on Invested Capital (ROIC)	-22.93%
Return on Capital Employed (ROCE)	-41.59%
Revenue Per Employee	$101
Profits Per Employee	-$777,264
Employee Count	227
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.08% in the last 52 weeks. The beta is 2.86, so FDMT's price volatility has been higher than the market average.

Beta (5Y)	2.86
52-Week Price Change	-87.08%
50-Day Moving Average	3.44
200-Day Moving Average	7.89
Relative Strength Index (RSI)	50.29
Average Volume (20 Days)	509,215

Short Selling Information

The latest short interest is 5.04 million, so 10.88% of the outstanding shares have been sold short.

Short Interest	5.04M
Short Previous Month	5.20M
Short % of Shares Out	10.88%
Short % of Float	14.68%
Short Ratio (days to cover)	6.03

Income Statement

In the last 12 months, FDMT had revenue of $23,000 and -$176.44 million in losses. Loss per share was -$3.18.

Revenue	23,000
Gross Profit	-154.11M
Operating Income	-203.33M
Pretax Income	-109.89M
Net Income	-176.44M
EBITDA	-198.80M
EBIT	-203.33M
Loss Per Share	-$3.18

Balance Sheet

The company has $321.44 million in cash and $23.85 million in debt, giving a net cash position of $434.59 million or $9.38 per share.

Cash & Cash Equivalents	321.44M
Total Debt	23.85M
Net Cash	434.59M
Net Cash Per Share	$9.38
Equity (Book Value)	469.72M
Book Value Per Share	10.14
Working Capital	305.67M

Cash Flow

In the last 12 months, operating cash flow was -$153.26 million and capital expenditures -$3.71 million, giving a free cash flow of -$156.96 million.

Operating Cash Flow	-153.26M
Capital Expenditures	-3.71M
Free Cash Flow	-156.96M
FCF Per Share	-$3.39

Margins

Gross Margin	n/a
Operating Margin	-884,026.09%
Pretax Margin	-767,126.09%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FDMT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.42%
Shareholder Yield	-28.42%
Earnings Yield	-114.72%
FCF Yield	-102.06%

Analyst Forecast

The average price target for FDMT is $32.33, which is 873.80% higher than the current price. The consensus rating is "Buy".

Price Target	$32.33
Price Target Difference	873.80%
Analyst Consensus	Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	394.04%
EPS Growth Forecast (5Y)	5.97%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FDMT has an Altman Z-Score of 6.75 and a Piotroski F-Score of 1.

Altman Z-Score	6.75
Piotroski F-Score	1